Reading view
Not Everything That Counts Can Be Counted: A Case for Safe Qualitative AI
Case Study: Transformer-Based Solution for the Automatic Digitization of Gas Plants
How do data owners say no? A case study of data consent mechanisms in web-scraped vision-language AI training datasets
Bio AI Agent: A Multi-Agent Artificial Intelligence System for Autonomous CAR-T Cell Therapy Development with Integrated Target Discovery, Toxicity Prediction, and Rational Molecular Design
Benevolent Dictators? On LLM Agent Behavior in Dictator Games
3D Guard-Layer: An Integrated Agentic AI Safety System for Edge Artificial Intelligence
GuardFed: A Trustworthy Federated Learning Framework Against Dual-Facet Attacks
AgentFlux: Decoupled Fine-Tuning & Inference for On-Device Agentic Systems
Simpliflow: A Lightweight Open-Source Framework for Rapid Creation and Deployment of Generative Agentic AI Workflows
LLM4AD: Large Language Models for Autonomous Driving - Concept, Review, Benchmark, Experiments, and Future Trends
Large Language Model Benchmarks in Medical Tasks
Asking the Right Questions: Benchmarking Large Language Models in the Development of Clinical Consultation Templates
Early Detection of Lung Cancer: A Review of Innovative Milestones and Techniques
J Clin Med. 2025 Nov 3;14(21):7812. doi: 10.3390/jcm14217812.
ABSTRACT
Lung cancer is the most frequently diagnosed cancer and the leading cause of cancer death worldwide. Early detection of lung cancer can lead to identification of the cancer at its initial treatable stages and improves survival. Low-dose CT scan (LDCT) is currently the gold standard for lung cancer screening in high-risk individuals. Despite the observed stage migration and consistently demonstrated disease-specific overall survival benefit, LDCT has inherent limitations, including false-positive results, radiation exposure, and low compliance. Recently, new techniques have been investigated for early detection of lung cancer. Several studies have shown that liquid biopsy biomarkers such as circulating cell-free DNA (cfDNA), microRNA molecules (miRNA), circulating tumor cells (CTCs), tumor-derived exosomes (TDEs), and tumor-educated platelets (TEPs), as well as volatile organic compounds (VOCs), have the power to distinguish lung cancer patients from healthy subjects, offering potential for minimally invasive and non-invasive means of early cancer detection. Furthermore, recent studies have shown that the integration of artificial intelligence (AI) with clinical, imaging, and laboratory data has provided significant advancements and can offer potential solutions to some challenges related to early detection of lung cancer. Adopting AI-based multimodality strategies, such as multi-omics liquid biopsy and/or VOCs' detection, with LDCT augmented by advanced AI, could revolutionize early lung cancer screening by improving accuracy, efficiency, and personalization, especially when combined with patient clinical data. However, challenges remain in validating, standardizing, and integrating these approaches into clinical practice. In this review, we described these innovative milestones and methods, as well as their advantages and limitations in screening and early diagnosis of lung cancer.
PMID:41227214 | PMC:PMC12609116 | DOI:10.3390/jcm14217812
Stereo-seq V2: Spatial mapping of total RNA on FFPE sections with high resolution
Embracing the Future of Medical Education With Large Language Model–Based Virtual Patients: Scoping Review
Equipping mathematical models for hospital dynamics using information theory
npj Digital Medicine, Published online: 12 November 2025; doi:10.1038/s41746-025-02013-2
Equipping mathematical models for hospital dynamics using information theory‘Tiny’ AI model beats massive LLMs at logic test
Nature, Published online: 13 November 2025; doi:10.1038/d41586-025-03379-9
Technique could be used as a cheap way to boost ability of other AI models.